Duplicate_University of California San Diego/ Moores Cancer Center /ID# 1128-0241 — La Jolla, California

Duplicate_University of California San Diego/ Moores Cancer Center /ID# 1128-0241 is a clinical research site located in La Jolla, California, United States 92037-0845.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Duplicate_University of California San Diego/ Moores Cancer Center /ID# 1128-0241 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma, Advanced Urothelial Carcinoma, Advanced Gastric Adenocarcinoma.

Sponsors: Pharmacyclics LLC..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duplicate_University of California San Diego/ Moores Cancer Center /ID# 1128-0241?

Duplicate_University of California San Diego/ Moores Cancer Center /ID# 1128-0241 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duplicate_University of California San Diego/ Moores Cancer Center /ID# 1128-0241 conducted?

Duplicate_University of California San Diego/ Moores Cancer Center /ID# 1128-0241 has 1 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma, Advanced Urothelial Carcinoma, Advanced Gastric Adenocarcinoma.

Is Duplicate_University of California San Diego/ Moores Cancer Center /ID# 1128-0241 accredited by Crixeo Health?

Duplicate_University of California San Diego/ Moores Cancer Center /ID# 1128-0241 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duplicate_University of California San Diego/ Moores Cancer Center /ID# 1128-0241?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.